Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014‐04 (Etoile du Nord) trial von Boyle, Eileen M., Leleu, Xavier, Petillon, Marie‐Odile, Karlin, Lionel, Doyen, Chantal, Demarquette, Hélène, Royer, Bruno, Macro, Margaret, Moreau, Philippe, Fostier, Karel, Marie‐Lorraine, Chretien, Zarnitsky, Charles, Perrot, Aurore, Herbaux, Charles, Poulain, Stephanie, Manier, Salomon, Beauvais, David, Walker, Brian A., Wardell, Christopher P., Vincent, Laure, Frenzel, Laurent, Caillon, Hélène, Susanna, Schraen, Dejoie, Thomas, Avet‐Loiseau, Hervé, Mohty, Mohamad, Facon, Thierry, Arnulf, Bertrand, Dib, Mamoun, Brechignac‐Bureau, Sabine, Godmer, Pascal, Tempescul, Adrian, Fohrer, Cecile, Benboubker, Lotfi, Voillat, Laurent, Malfuson, Jean Valère, Mariette, Clara, Tiab, Mourad, Rigaudeau, Sophie, Jaccard, Arnaud, Stoppa, Anne‐Marie, Eisenmann, Jean‐Claude, Rodon, Philippe, Kolb, Brigitte, Decaux, Olivier, Onraed, Brigitte, Attal, Michel, Hulin, Cyrille

Volltext